The government proposed amendments that would set up an inventory control mechanism to prevent panic buying and drug hoarding following the planned withdrawal of some drugs from the Taiwanese market, Minister of Health and Welfare Shih Chung-liang (石崇良) said yesterday.
Food and Drug Administration (FDA) data showed that as of the end of last month, 47 drugs are to be withdrawn from the Taiwanese market.
Most of these drugs have alternative options, the FDA said, adding that 25 share the same ingredients, dosages and dosage forms with other generic drugs, and 21 have substitutes with the same ingredients or mechanisms.
Photo: Chung Li-hua, Taipei Times
Only one drug would stop production by the end of next year, it said.
Shih yesterday said that the FDA has submitted proposed amendments to the Pharmaceutical Affairs Act (藥事法), which would require pharmaceutical companies to report plans to discontinue a drug’s production at least six months in advance.
The amendment also seeks to authorize the FDA to control the inventory of drugs when facing a supply shortage, he said, adding that the ministry plans to initiate a special drug import project in response to the planned discontinuation of an immunosuppressive drug next year.
Although pharmaceutical companies reported that supplies of the 47 drugs would be unstable over the next six months due to reduced production or plans to exit the market, only immunosuppressive agent cyclosporine would stop being produced, Shih said.
The company would continue to supply the drug until the end of the year, he said.
Companies that produce essential medicines must report to the FDA six months in advance if they plan to reduce production or withdraw from the market, but that is not mandatory for non-essential drugs, Shih said.
Sometimes those are reported at short notice, leaving the FDA with very limited time to assess and respond to the situation, he added.
The proposed amendment includes three main points, Shih said.
First, companies that produce any type of drug would be required to report to the FDA plans to reduce or stop production at least six months in advance.
Second, the FDA would be authorized to oversee inventory control when a drug is facing potential supply shortage due to discontinuation or lower production.
Hospitals often scramble to stock up on those drugs, causing other hospitals or pharmacies to experience a shortage earlier, he said.
Third, companies would be asked whether they want to adjust their drug prices.
The National Health Insurance Administration had asked the companies producing the 47 drugs if they want to change their prices, but they said their plan to discontinue supply was due to global supply readjustment, not pricing, Shih said.
Faced with potential drug price increases due to US President Donald Trump’s new tariffs, the special resilience act has allocated NT$20 billion (US$654.8 million) for drug price adjustments, he said.
However, for long-term drug industry resilience, the ministry must boost the public’s confidence in generic drugs, he added.
Additional reporting by Chiu Chih-jou
LIMITS: While China increases military pressure on Taiwan and expands its use of cognitive warfare, it is unwilling to target tech supply chains, the report said US and Taiwan military officials have warned that the Chinese People’s Liberation Army (PLA) could implement a blockade within “a matter of hours” and need only “minimal conversion time” prior to an attack on Taiwan, a report released on Tuesday by the US Senate’s China Economic and Security Review Commission said. “While there is no indication that China is planning an imminent attack, the United States and its allies and partners can no longer assume that a Taiwan contingency is a distant possibility for which they would have ample time to prepare,” it said. The commission made the comments in its annual
DETERMINATION: Beijing’s actions toward Tokyo have drawn international attention, but would likely bolster regional coordination and defense networks, the report said Japanese Prime Minister Sanae Takaichi’s administration is likely to prioritize security reforms and deterrence in the face of recent “hybrid” threats from China, the National Security Bureau (NSB) said. The bureau made the assessment in a written report to the Legislative Yuan ahead of an oral report and questions-and-answers session at the legislature’s Foreign Affairs and National Defense Committee tomorrow. The key points of Japan’s security reforms would be to reinforce security cooperation with the US, including enhancing defense deployment in the first island chain, pushing forward the integrated command and operations of the Japan Self-Defense Forces and US Forces Japan, as
‘TROUBLEMAKER’: Most countries believe that it is China — rather than Taiwan — that is undermining regional peace and stability with its coercive tactics, the president said China should restrain itself and refrain from being a troublemaker that sabotages peace and stability in the Indo-Pacific region, President William Lai (賴清德) said yesterday. Lai made the remarks after China Coast Guard vessels sailed into disputed waters off the Senkaku Islands — known as the Diaoyutai Islands (釣魚台) in Taiwan — following a remark Japanese Prime Minister Sanae Takaichi made regarding Taiwan. Takaichi during a parliamentary session on Nov. 7 said that a “Taiwan contingency” involving a Chinese naval blockade could qualify as a “survival-threatening situation” for Japan, and trigger Tokyo’s deployment of its military for defense. Asked about the escalating tensions
The Ministry of Economic Affairs said it plans to revise the export control list for strategic high-tech products by adding 18 items under three categories — advanced 3D printing equipment, advanced semiconductor equipment and quantum computers — which would require local manufacturers to obtain licenses for their export. The ministry’s announcement yesterday came as the International Trade Administration issued a 60-day preview period for planned revisions to the Export Control List for Dual Use Items and Technology (軍商兩用貨品及技術出口管制清單) and the Common Military List (一般軍用貨品清單), which fall under regulations governing export destinations for strategic high-tech commodities and specific strategic high-tech commodities. The
RSS